Rare diseases
Investigational molecules
Locations
Phase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis
GermanyEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
GermanyA study to assess the effect of elecoglipron alone and in combination with dapagliflozin on blood sugar control in adults with Type 2 diabetes
GermanyRandomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function
GermanyA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
GermanySafety Study of CD19.CAR T Cells in Patients with Autoimmune‑Associated Severe Interstitial Lung Fibrosis
GermanyStudy of BGB-43395 with letrozole versus CDK4/6 inhibitor drug combination with letrozole in patients with untreated advanced HR‑positive HER2‑negative breast cancer
GermanyPhase II study of intratumoral getacatetide in patients with locally advanced or metastatic adrenocortical carcinoma
GermanyEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
GermanyPhase III randomized trial of elecoglipron to assess safety and weight loss in adults with obesity or overweight, with or without type 2 diabetes
GermanyA Study of ABBV-706 to Assess Safety and Efficacy Compared with Standard Drug Combination in Adults with Relapsed or Refractory Small Cell Lung Cancer
GermanyDurvalumab plus drug combination as total neoadjuvant therapy for patients with resectable gastroesophageal adenocarcinoma
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
